CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,307,135
- in 1 filing, $6.3M under 10b5-1 plans
Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-03 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −5,880 | $449.84 | $2.6M | 57,946 |
| 2025-12-03 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −5,809 | $451.20 | $2.6M | 52,137 |
| 2025-12-03 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −15,681 | $452.20 | $7.1M | 36,456 |
| 2025-12-03 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −10,360 | $453.34 | $4.7M | 26,096 |
| 2025-12-03 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −2,070 | $455.22 | $942K | 24,026 |
| 2025-12-03 | LEIDEN JEFFREY M Executive Chairman | Option exercise · Stock Option (Right to Buy) 10b5-1 | −63,781 | 0 | ||
| 2025-12-03 | Biller Jonathan EVP and Chief Legal Officer | Sale 10b5-1 | −347 | $449.00 | $156K | 15,306 |
| 2025-11-19 | CARNEY LLOYD Director | Gift | −800 | 6,315 | ||
| 2025-11-17 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Sale 10b5-1 | −2,500 | $434.58 | $1.1M | 16,852 |
| 2025-11-14 | LEIDEN JEFFREY M Executive Chairman | Option exercise 10b5-1 | +13,835 | $91.05 | $1.3M | 37,861 |
| 2025-11-14 | LEIDEN JEFFREY M Executive Chairman | Option exercise 10b5-1 | +39,769 | $86.52 | $3.4M | 77,630 |
| 2025-11-14 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −32,234 | $440.30 | $14.2M | 45,396 |
| 2025-11-14 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −21,330 | $441.35 | $9.4M | 24,066 |
| 2025-11-14 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −40 | $442.00 | $18K | 24,026 |
| 2025-11-14 | LEIDEN JEFFREY M Executive Chairman | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,835 | 1 | ||
| 2025-11-14 | LEIDEN JEFFREY M Executive Chairman | Option exercise · Stock Option (Right to Buy) 10b5-1 | −39,769 | 63,781 | ||
| 2025-11-13 | LEIDEN JEFFREY M Executive Chairman | Option exercise 10b5-1 | +19,688 | $91.05 | $1.8M | 43,714 |
| 2025-11-13 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −18,528 | $440.22 | $8.2M | 25,186 |
| 2025-11-13 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −1,160 | $441.05 | $512K | 24,026 |
| 2025-11-13 | LEIDEN JEFFREY M Executive Chairman | Option exercise · Stock Option (Right to Buy) 10b5-1 | −19,688 | 13,836 |
Page 11 of 18 · 344 trades